Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses induction therapy for multiple myeloma, highlighting the remarkable efficacy of daratumumab-based quadruplet therapies. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.